InterCure And Berner’s Cookies Launch Flagship Retail Location In Vienna, Austria
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) opened the first flagship Cookies store in Austria, located in the Neubau district of Vienna.
InterCure And Berner’s Cookies Launch Flagship Cannabis Pharmacy In Be’er Sheva, Israel
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) is opening its flagship Cookies pharmacy in Be'er Sheva, the largest city in Israel's southern region, known as the capital of the Negev.
InterCure Begins 2022 With Record-Breaking Q1 Financial Results, Up 9% Sequentially From Prior Quarter
InterCure (NASDAQ: INCR) released its financial results for the first quarter of 2022 and provided shareholders with a business update. All amounts are expressed in Canadian dollars or New Israeli Shekels (NIS) unless otherwise noted.
This Analyst Has Mixed Feelings About Tilray’s Promise To Achieve $4B In Revenue By 2024, Here’s Why
Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date.
InterCure Reports Record FY 2021 Revenue Of $89M, Q4 Adjusted EBITDA Spikes 140% YoY
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, has announced its estimated financial and operating results for the fourth quarter and year ended December 31, 2021.
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results
Clever Leaves Holdings Inc. (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the fourth quarter and full-year ended December 31, 2021.
Berner: Rapper, Entrepreneur, Social Justice Advocate To Participate In Benzinga Psychedelics Capital Conference
Berner, the Bay Area artist and entrepreneur recently expanded the
Israel Set To Decriminalize Rec Cannabis As More Marijuana Businesses Join The Emerging Market
It seems that Israel is taking steps toward the legalization of recreational cannabis, with the government considering fully decriminalizing adult use.
Israel Moves To Normalize CBD, Two-Year Path To Market Expected
Israel recently took steps toward normalizing CBD and related cannabinoids, declaring the hemp compound is not a drug, though observers say the path to market for such products is likely to be a long one.